title: Response to Comment on Wu and Spiegelman. Irisin ERKs the fat. Diabetes 2014;63:381-383.
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA bruce_spiegelman@dfci.harvard.edu.
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Spiegelman
authors.affiliation: Spiegelman Laboratory, Cancer Biology, Department of Cell Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
authors.forename: Christiane
authors.initials: C
authors.lastname: Wrann
mesh_terms: D017667:Adipocytes / Q000166:cytology*; D000818:Animals; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D005353:Fibronectins / Q000494:pharmacology*; D020935:MAP Kinase Signaling System / Q000502:physiology*; D008297:Male; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D005353:Fibronectins; D048049:Extracellular Signal-Regulated MAP Kinases; D048051:p38 Mitogen-Activated Protein Kinases